Sandoparin dihydroergotamine. A combination preparation for prevention of thrombosis
Wille-Jørgensen, P.A.
Ugeskrift for Laeger 153(34): 2370-2372
1991
ISSN/ISBN: 0041-5782 PMID: 1897057 Document Number: 376637
Document emailed within 1 workday
Related Documents
Haas, S. 1995: Combination of low molecular weight heparin and dihydroergotamine for prevention of thrombosis Deutsche Medizinische Wochenschrift 120(14): 503Burkhardt, H.; Röll, G. 1974: Combined prevention of thrombosis. Combination of anticoagulant therapy with preparations inhibiting platelet aggregation Die Medizinische Welt 25(19): 867-869
Vayssairat, M.; Fiessinger, J.N.; Bequemin, M.H.; Housset, E. 1978: Dihydroergotamine and triacetyloleandomycin combination. its role in iatrogenic necrosis of the fingers La Nouvelle Presse Medicale 7(23): 2077
Bacourt, F.; Couffinhal, J.C. 1978: Ischemia of the extremities caused by a combination of dihydroergotamine and triacetyloleandomycin. New case report La Nouvelle Presse Medicale 7(18): 1561
Lindblad, B. 1988: Prophylaxis of postoperative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. a review Acta Chirurgica Scandinavica. Supplementum 543: 31-42
Pradalier, A.; Guérard des Lauriers, A.; Scheck, F.; Peraudeau, P.; Lacoste, J.P.; Cajfinger, F. 1995: Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks Pathologie-Biologie 43(9): 806-813
Heuser, B.; Middendorf, E. 1985: Migraine prevention with dihydroergotamine Fortschritte der Medizin 103(41): 966-970
Haas, S.; Stemberger, A.; Fritsche, H.M.; Welzel, D.; Wolf, H.; Lechner, F.; Blümel, G. 1987: Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine Arzneimittel-Forschung 37(7): 839-843
Langohr, H.D.; Reinecke, M.; Gerber, W.D.; Mangold, R. 1988: Dihydroergotamine and flunarizine in the prevention of migraine. A comparative double-blind study Fortschritte der Medizin 106(2): 65
Kakkar, V.V.; Bentley, P.G.; Lawrence, D.; de Haas, H.A.; Ward, V.P. 1979: Prevention of postoperative venous thromboembolism by means of heparin and dihydroergotamine after hip joint replacement Münchener Medizinische Wochenschrift 121(36): 1152-1154
Hess, L. 1991: Anesthesia in dogs with the combination preparation Tilest 500 Tierarztliche Praxis 19(1): 107-110
Reuther, J.; Hausamen, J.E. 1974: Clinical evaluation of a new combination preparation for analgesia in oral surgery Die Medizinische Welt 25(18): 812-816
Bokarewa, M.I.; Blombäck, M. 1997: Combination of activated protein C resistance and antibodies to phospholipids in the development of thrombosis Seminars in Hematology 34(3): 235-243
Hampel, R.; Meng, W.; Weber, A.; Meng, S.; Ventz, M. 1980: Problems of treatment with thyroid hormones. Thyroxin monotherapy or a T3/T4 combination preparation? Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 35(6): 258-261
Huang, H.L.; Rao, M.R. 1995: Effects of neferine and its combination with taurine on platelet aggregation and experimental thrombosis in rats Yao Xue Xue Bao 30(7): 486-490
Shvartsman, I.S.; Ispolatova, A.V.; Tsybul'skaia, N.V.; Shapiro, N.I.; Aksenov, O.A. 1982: Immunization with a complex preparation: a new method of influenza prevention. The basis for using a complex preparation for preventing influenza Voprosy Virusologii 27(2): 142-146
Vasil'ev, V.K. 1976: Pharmacokinetics of penicillins in the blood of dogs administered the combination preparation, ampiox, internally Antibiotiki 21(11): 1000-1002
Dettwiler, M.; Straub, R.; Heitmann, H.H.; Gysin, J. 1987: Pharmacokinetics of a trimethoprim/sulfadimidine combination preparation (ROTA-TS) after a single oral administration in the horse Schweizer Archiv für Tierheilkunde 129(9): 473-480
Chen, Z.-h. 2014: Application of sonic endo-instruments in combination with Mtwo Ni-Ti files in root canal preparation of molars Shanghai Kou Qiang Yi Xue 23(5): 624-627
Weuta, H. 1974: Clinical investigation of a combination preparation of ampicillin, theophylline, papaverine-HCl and guaiacolglyceryl ether. 1. in form of tablets Arzneimittel-Forschung 24(12): 2035-2044